Breaking News

SGD Pharma Invests $21.7M to Upgrade Zhanjiang Plant

Investment includes a complete rebuild of the plant’s furnace and improvement of the plant’s facilities.

Author Image

By: Charlie Sternberg

Associate Editor

SGD Pharma, a global provider of primary glass packaging for pharmaceutical and cosmetic products, has invested more than €20 million ($21.7 million) to upgrade its Zhanjiang plant in China, including a complete rebuild of its furnace and comprehensive improvement of the plant’s facilities.   Using advanced design and technologies, this new furnace allows the Zhanjiang plant to increase capacity, improve energy performance and minimize energy consumption, reducing the Group’s carbon footprint ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters